We are international
Donate
• about myeloma TEXT SIZE   
Ask Dr Durie

ask_dr_durie_banner

 

Have a question? Submit it to AskDrDurie@myeloma.org!
 

facebook
googleplus
twitter
youtube


IMF Chairman and Co-Founder Brian G.M. Durie, MD welcomes your questions about the latest myeloma treatments, research, controversies and quality of life issues. If you have a question you think might be of interest to the myeloma community, please send to askdrdurie@myeloma.org! For questions of a specific personal nature, please call the IMF InfoLine coordinators at 800.452.2873 or email them at infoline@myeloma.org.

Our archives are brimming with useful information directed at - and asked by - patients, caregivers, and other interested parties... so please watch the episodes below, and share them as much as possible so that others may benefit!


 

 

 

#Ask Dr. Durie
previous     next      view all

07.09.14   #AskDrDurie: Can a low white blood cell count be enough to trigger a need for myeloma therapy?

In this episode of #AskDrDurie, IMF Chairman and Co-Founder Dr. Brian G.M. Durie talks about what a low white blood cell count means when it comes to myeloma.


07.02.14   #AskDrDurie: Does age make a difference in selecting myeloma treatment?

In this episode of #AskDrDurie, IMF Chairman and Co-Founder Dr. Brian G.M. Durie discusses the important factors one must consider when selecting individualized treatment for myeloma.


06.25.14   #AskDrDurie: Is MRI testing important to see if treatment is necessary for smoldering myeloma?

In this episode of #AskDrDurie, Dr. Brian Durie discusses the importance of MRI testing, specifically when it comes to patients with smoldering myeloma.


06.18.14   #AskDrDurie: Are there maintenance therapy recommendations for myeloma patients with t(4;14)?

In this episode of #AskDrDurie, IMF Chairman and Co-Founder Dr. Brian G.M. Durie addresses a question about what kind of maintenance therapy is recommended for those myeloma patients who have the t(4;14) chromosome abnormality.


06.12.14   #AskDrDurie: Are clinical trials part of the Black Swan Research Initiative(R), and if so, how can I participate?

In this episode of #AskDrDurie, Dr. Brian Durie, IMF Chairman and Co-Founder, talks about the Black Swan Research Initiative(R)'s various clinical trials and how eligible patients can get more information and potentially participate in them.


06.04.14   #AskDrDurie: How does the new flow cytometry testing for MRD compare to molecular testing?

In this episode of #AskDrDurie, Dr. Brian G.M. Durie, IMF Chairman and Co-Founder, discusses the sensitivity and accessibility of the flow cytometry method of MRD testing. 


05.22.14   #AskDrDurie: Are PET/CT scans useful for a patient with MGUS?

In this episode of #AskDrDurie, Dr. Brian G.M. Durie, IMF Chairman, explains what MGUS means and why PET/CT scans are the most effective way to exclude unsuspected lesions that may occur in patients.


05.15.14   #AskDrDurie: In light of Tom Brokaw's recent myeloma diagnosis, is better early screening required?"

In this episode of #AskDrDurie, Dr. Brian G.M. Durie, IMF Chairman, discusses the importance of early detection screenings in order to diagnose myeloma. Find out why there is a constant need for awareness and monitoring of any changes in test results.


05.08.14   #AskDrDurie: Should Patients With Similar Types of Myeloma Form Separate Support Groups?

05.01.14   #AskDrDurie: If Myeloma Is Diagnosed, Is It Okay to Start With A Holistic Type of Approach First?

previous     next      view all